Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Radiosensitization of clioquinol and zinc in human cancer cell lines
Clioquinol combined with zinc inhibited NF-κB activation.
»
04/20/18
Stereotactic body radiation therapy as an effective and safe treatment for small hepatocellular carcinoma
CyberKnife treatment safe and effective option for sHCC.
»
04/20/18
Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS/NO and inhibition of the Akt signalling pathway.
CuD activated mitochondrial apoptosis pathway.
»
10/14/17
Two long non-coding RNAs, Prcat17.3 and Prcat38, could efficiently discriminate benign prostate hyperplasia from prostate cancer.
Real-time RT-PCR analyses on urine samples of prostate cancer patients revealed elevated prcat17.3 level.
»
01/30/18
Circulating tumor DNA testing in advanced non-small cell lung cancer.
Mutations identified in ctDNA can predict responses to targeted therapies.
»
07/10/17
Does the gastrointestinal microbiome contribute to the "obesity paradox" in melanoma survival?
Anti-CTLA-4 therapy, may depend on the composition of the gut bacteria flora.
»
04/18/18
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
Black patients had inferior PRQOL and overall survival.
»
12/14/17
Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.
Recent IUD use had variable weak associations with CIN2+.
»
01/18/18
Deptor is a novel target of Wnt/β-catenin/c-Myc and contributes to colorectal cancer cell growth.
Deptor, suppressor of mTOR, direct target of Wnt/β-catenin/c-Myc signaling.
»
04/11/18
Differential effects of estrogen receptor beta isoforms on glioblastoma progression.
ERβ1 cells exhibited lower activation of mTOR signaling molecules.
»
04/11/18
< Prev
Next >